Owner Amylin Pharmaceuticals, Inc.

Inventors Young, Andrew; Prickett, Kathryn

Agent Spruson & Ferguson

Pub. Number AU-B-2004220727

Parent 775063

Filing date 14 October 2004

Wipo publication date 11 November 2004

Acceptance publication date 11 October 2007

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/48 (2006.01) Drugs for disorders of the endocrine system

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

C07K 1/04 (2006.01) General processes for the preparation of peptides

C07K 14/46 (2006.01) Peptides having more than 20 amino acids